According to Quidel, the assay is the first rapid antigen test for detecting all three viruses simultaneously to receive EUA.
By enabling three tests to be performed simultaneously on a single cartridge using a single swab sample, the company can scale seasonal production of flu tests without impacting its scheduled ramp of COVID-19 antigen test capacity.